Core Scientific (NASDAQ:CORZ) Upgraded to Hold at Wall Street Zen

Wall Street Zen upgraded shares of Core Scientific (NASDAQ:CORZ) from a sell rating to a hold rating in a research note issued to investors on Saturday morning,Wall Street Zen reports.

A number of other brokerages have also weighed in on CORZ. Freedom Capital raised Core Scientific from a “hold” rating to a “strong-buy” rating in a research report on Thursday, July 30th. Capital One Financial set a $33.00 price target on shares of Core Scientific in a report on Thursday, July 30th. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $39.00 price target on shares of Core Scientific in a report on Wednesday, October 14th. Compass Point reiterated a “buy” rating and issued a $36.00 price target on shares of Core Scientific in a research note on Wednesday, July 29th. Finally, Canaccord Genuity Group reissued a “buy” rating and set a $36.00 price objective on shares of Core Scientific in a report on Thursday, October 15th. Two research analysts have rated the stock with a Strong Buy rating, seventeen have assigned a Buy rating, two have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $30.54.

Core Scientific Price Performance

Shares of NASDAQ:CORZ opened at $11.76 on Friday. The company has a market cap of $3.78 billion, a P/E ratio of -3.37 and a beta of 5.56. Core Scientific has a 1 year low of $10.59 and a 1 year high of $30.46. The stock’s fifty day moving average price is $15.68 and its 200-day moving average price is $19.48.

Core Scientific (NASDAQ:CORZ) last released its quarterly earnings data on Thursday, November 5th. The company reported $0.47 EPS for the quarter, beating the consensus estimate of ($0.07) by $0.54. Core Scientific had a negative return on equity of 64.77% and a negative net margin of 18.31%. The company had revenue of $232.87 million for the quarter, compared to analysts’ expectations of $196.54 million. On average, sell-side analysts anticipate that Core Scientific will post -1.36 earnings per share for the current year.

Insider Activity

In other news, insider Todd DuChene sold 10,000 shares of the firm’s stock in a transaction on Monday, October 19th. The stock was sold at an average price of $13.87, for a total value of $138,700.00. Following the transaction, the insider directly owned 1,143,286 shares in the company, valued at $15,857,376.82. This trade represents a 0.87% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at this link. In the last quarter, insiders acquired 19,000 shares of company stock valued at $342,290 and sold 100,000 shares valued at $1,628,600. 1.70% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

A number of institutional investors have recently bought and sold shares of the company. BlackRock Inc. bought a new position in Core Scientific in the second quarter worth approximately $719,649,000. Apollo Management Holdings L.P. purchased a new position in shares of Core Scientific during the 2nd quarter worth $115,671,000. Fifth Third Bancorp purchased a new position in shares of Core Scientific during the 1st quarter worth $59,802,000. Avala Global LP purchased a new position in shares of Core Scientific during the 2nd quarter worth $101,729,000. Finally, Bank of America Corp DE grew its position in shares of Core Scientific by 412.5% during the 1st quarter. Bank of America Corp DE now owns 4,806,363 shares of the company’s stock valued at $71,903,000 after acquiring an additional 3,868,535 shares during the period.

Key Stories Impacting Core Scientific

Here are the key news stories impacting Core Scientific this week:

• Positive Sentiment: Core Scientific reported Q3 2026 earnings of $0.47 per share, versus analysts’ expected loss, while revenue of $232.87 million also exceeded estimates. The results provide a fundamental catalyst for investor optimism. Core Scientific surpasses Q3 earnings and revenue estimates
• Positive Sentiment: Traders bought 143,273 CORZ call options Friday, about 127% above average volume. The surge may reflect increased bullish speculation, though options activity does not guarantee future gains.
• Neutral Sentiment: Needham cut its price target from $35 to $28 but maintained a Buy rating. The lower target tempers the outlook, while the continued Buy rating signals the analyst still sees substantial potential upside relative to the cited $11.76 price.
• Negative Sentiment: Insider Todd Duchene sold 10,000 shares for $127,800, reducing his holdings by 0.88%. The sale is a modest cautionary signal, although he retained more than 1.1 million shares. Core Scientific insider sale

Core Scientific Company Profile

Core Scientific, Inc is a digital infrastructure company that develops and operates data centers for high-performance computing. The company has historically focused on bitcoin mining, using specialized computing equipment and supporting infrastructure to validate transactions on the Bitcoin network. It also provides hosting and infrastructure services for other digital asset miners.

Core Scientific is expanding its business toward hosting high-performance computing and artificial intelligence workloads.